Founded in 1906, Norgine is a leading European specialist pharmaceutical company that has been bringing transformative medicines to patients for over a century.
We understand the complexities of the diverse European healthcare systems and have a flexible and agile structure as well as a direct presence in 14 European countries.
This enables us to acquire, develop and commercialise specialist and innovative products that make a real difference to the lives of patients. We also have a direct presence in Australia and New Zealand as well as a strong global network of partnerships in non-Norgine markets to bring our transformative products to patients around the world. As a consequence, we help over 20 million patients every year.